BNP Paribas Financial Markets’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $87.2K | Buy |
28,413
+19,456
| +217% | +$84.3K | ﹤0.01% | 4442 |
|
|
2025
Q4 | $31.9K | Sell |
8,957
-24,822
| -73% | -$152K | ﹤0.01% | 4887 |
|
|
2025
Q3 | $301K | Buy |
33,779
+3,035
| +10% | +$30.8K | ﹤0.01% | 3807 |
|
|
2025
Q2 | $283K | Sell |
30,744
-21,322
| -41% | -$182K | ﹤0.01% | 3636 |
|
|
2025
Q1 | $447K | Buy |
52,066
+42,861
| +466% | +$405K | ﹤0.01% | 3253 |
|
|
2024
Q4 | $98.9K | Sell |
9,205
-5,869
| -39% | -$45.1K | ﹤0.01% | 4167 |
|
|
2024
Q3 | $85.6K | Buy |
15,074
+7,421
| +97% | +$42.8K | ﹤0.01% | 3502 |
|
|
2024
Q2 | $32.3K | Sell |
7,653
-38,874
| -84% | -$157K | ﹤0.01% | 3564 |
|
|
2024
Q1 | $237K | Sell |
46,527
-64,505
| -58% | -$363K | ﹤0.01% | 3206 |
|
|
2023
Q4 | $1.03M | Buy |
111,032
+28,297
| +34% | +$195K | ﹤0.01% | 2372 |
|
|
2023
Q3 | $542K | Buy |
82,735
+11,439
| +16% | +$91K | ﹤0.01% | 2681 |
|
|
2023
Q2 | $580K | Sell |
71,296
-99,600
| -58% | -$854K | ﹤0.01% | 2511 |
|
|
2023
Q1 | $1.46M | Buy |
170,896
+40,815
| +31% | +$407K | ﹤0.01% | 2054 |
|
|
2022
Q4 | $1.2M | Buy |
130,081
+28,027
| +27% | +$299K | ﹤0.01% | 2060 |
|
|
2022
Q3 | $1.05M | Buy |
102,054
+85,816
| +528% | +$906K | ﹤0.01% | 2450 |
|
|
2022
Q2 | $163K | Buy |
16,238
+4,553
| +39% | +$43.1K | ﹤0.01% | 3176 |
|
|
2022
Q1 | $144K | Sell |
11,685
-2,248
| -16% | -$27.6K | ﹤0.01% | 3244 |
|
|
2021
Q4 | $242K | Buy |
13,933
+2,519
| +22% | +$47.9K | ﹤0.01% | 3320 |
|
|
2021
Q3 | $205K | Buy |
11,414
+9,169
| +408% | +$183K | ﹤0.01% | 3031 |
|
|
2021
Q2 | $51.3K | Sell |
2,245
-22,116
| -91% | -$328K | ﹤0.01% | 3254 |
|
|
2021
Q1 | $364K | Buy |
24,361
+14,083
| +137% | +$154K | ﹤0.01% | 2750 |
|
|
2020
Q4 | $55.5K | Sell |
10,278
-2,086
| -17% | -$11K | ﹤0.01% | 3507 |
|
|
2020
Q3 | $56.3K | Buy |
12,364
+10,156
| +460% | +$43.7K | ﹤0.01% | 3418 |
|
|
2020
Q2 | $10.9K | Sell |
2,208
-11,878
| -84% | -$44.9K | ﹤0.01% | 3669 |
|
|
2020
Q1 | $44.4K | Buy |
14,086
+7,978
| +131% | +$27.8K | ﹤0.01% | 3598 |
|
|
2019
Q4 | $15.8K | Buy |
6,108
+536
| +10% | +$1.41K | ﹤0.01% | 4056 |
|
|
2019
Q3 | $17.6K | Buy |
5,572
+4,073
| +272% | +$11.8K | ﹤0.01% | 4001 |
|
|
2019
Q2 | $5.05K | Buy |
1,499
+95
| +7% | +$295 | ﹤0.01% | 4241 |
|
|
2019
Q1 | $4.28K | Hold |
1,404
| – | – | ﹤0.01% | 4084 |
|
|
2018
Q4 | $2.19K | Buy |
1,404
+94
| +7% | +$213 | ﹤0.01% | 3785 |
|
|
2018
Q3 | $3.58K | Hold |
1,310
| – | – | ﹤0.01% | 4161 |
|
|
2018
Q2 | $3.43K | Sell |
1,310
-7,391
| -85% | -$20.6K | ﹤0.01% | 4186 |
|
|
2018
Q1 | $24K | Buy |
8,701
+913
| +12% | +$2.58K | ﹤0.01% | 3879 |
|
|
2017
Q4 | $25.1K | Buy |
7,788
+4,969
| +176% | +$19.6K | ﹤0.01% | 3921 |
|
|
2017
Q3 | $11.7K | Buy |
2,819
+443
| +19% | +$1.97K | ﹤0.01% | 3823 |
|
|
2017
Q2 | $12.6K | Buy |
+2,376
| New | +$13.7K | ﹤0.01% | 3883 |
|
|
2017
Q1 | – | Sell |
-224
| Closed | -$887 | – | 4087 |
|
|
2016
Q4 | $887 | Sell |
224
-1,995
| -90% | -$7.11K | ﹤0.01% | 4025 |
|
|
2016
Q3 | $8.05K | Buy |
2,219
+928
| +72% | +$3.91K | ﹤0.01% | 3272 |
|
|
2016
Q2 | $7.89K | Buy |
+1,291
| New | +$6.24K | ﹤0.01% | 3037 |
|
Other funds holding AVXL
VCM
SF
VPM